Surgical Science Sweden Stock Market Value
| SUSRF Stock | USD 2.84 0.57 16.72% |
| Symbol | Surgical |
Surgical Science 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Surgical Science's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Surgical Science.
| 11/17/2025 |
| 02/15/2026 |
If you would invest 0.00 in Surgical Science on November 17, 2025 and sell it all today you would earn a total of 0.00 from holding Surgical Science Sweden or generate 0.0% return on investment in Surgical Science over 90 days. Surgical Science is related to or competes with Vitalhub Corp, COLTENE Holding, Cogstate, BioInvent International, Knight Therapeutics, Avacta Group, and Kneat. Surgical Science Sweden AB develops and markets virtual reality simulators for evidence-based laparoscopic and endoscopi... More
Surgical Science Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Surgical Science's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Surgical Science Sweden upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.17) | |||
| Maximum Drawdown | 58.28 | |||
| Value At Risk | (2.78) |
Surgical Science Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Surgical Science's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Surgical Science's standard deviation. In reality, there are many statistical measures that can use Surgical Science historical prices to predict the future Surgical Science's volatility.| Risk Adjusted Performance | (0.12) | |||
| Jensen Alpha | (1.14) | |||
| Total Risk Alpha | (1.82) | |||
| Treynor Ratio | 0.6902 |
Surgical Science February 15, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.12) | |||
| Market Risk Adjusted Performance | 0.7002 | |||
| Mean Deviation | 2.46 | |||
| Coefficient Of Variation | (611.07) | |||
| Standard Deviation | 7.6 | |||
| Variance | 57.7 | |||
| Information Ratio | (0.17) | |||
| Jensen Alpha | (1.14) | |||
| Total Risk Alpha | (1.82) | |||
| Treynor Ratio | 0.6902 | |||
| Maximum Drawdown | 58.28 | |||
| Value At Risk | (2.78) | |||
| Skewness | (7.07) | |||
| Kurtosis | 52.64 |
Surgical Science Sweden Backtested Returns
Surgical Science Sweden owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.16, which indicates the firm had a -0.16 % return per unit of risk over the last 3 months. Surgical Science Sweden exposes nineteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Surgical Science's Coefficient Of Variation of (611.07), risk adjusted performance of (0.12), and Variance of 57.7 to confirm the risk estimate we provide. The entity has a beta of -1.82, which indicates a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Surgical Science are expected to decrease by larger amounts. On the other hand, during market turmoil, Surgical Science is expected to outperform it. At this point, Surgical Science Sweden has a negative expected return of -1.24%. Please make sure to validate Surgical Science's total risk alpha and day median price , to decide if Surgical Science Sweden performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.19 |
Very weak predictability
Surgical Science Sweden has very weak predictability. Overlapping area represents the amount of predictability between Surgical Science time series from 17th of November 2025 to 1st of January 2026 and 1st of January 2026 to 15th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Surgical Science Sweden price movement. The serial correlation of 0.19 indicates that over 19.0% of current Surgical Science price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.19 | |
| Spearman Rank Test | 0.15 | |
| Residual Average | 0.0 | |
| Price Variance | 0.03 |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Surgical Pink Sheet
Surgical Science financial ratios help investors to determine whether Surgical Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Surgical with respect to the benefits of owning Surgical Science security.